This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dow, L. W. Articles by Fridland, A. Search for Related Content PubMed PubMed Citation Articles by Dow, L. W. Articles by Fridland, A.

Differences in Metabolism and Cytotoxicity between 9-ß-D-Arabinofuranosyladenine and 9-ß-D-Arabinofuranosyl-2-fluoroadenine in Human Leukemic Lymphoblasts¹

Divisions of Biochemical and Clinical Pharmacology [A. F., D. E. B.] and Hematology-Oncology [L. W. D., L. P.], St. Jude Children's Research Hospital, Memphis, Tennessee 38101

We compared the effects of 9-ß-D-arabinofuranosyladenine (ara-A) and its 2-fluoro derivative (F-ara-A) on DNA synthesis and viability in human leukemic lymphoblasts (CCRF-CEM). The relative DNA content and cloning capacity of the cells were determined by flow cytometry and growth in methylcellulose, respectively. Incubation with either 1 µM ara-A in the presence of 2'-deoxycoformycin, a potent inhibitor of adenosine deaminase, or 2.5 µM F-ara-A alone for 18 hr stopped the progression of cells through S phase. At higher concentrations, from 2.5 to 20 µM, both arabinonucleosides preferentially produced toxic effects in cells arrested in S phase. The DNA-inhibitory effects and cytotoxicity of F-ara-A, but not ara-A, were prevented by adding deoxycytidine to the growth medium. A CCRF-CEM variant that was unable to phosphorylate deoxycytidine proved to be highly resistant to the inhibitory effects of F-ara-A but was normally sensitive to ara-A. These results indicate that the cytotoxicity of ara-A in both sensitive and resistant cells and of F-ara-A in sensitive cells is probably mediated by the intracellular formation of nucleotides and inhibition of DNA synthesis. By contrast, the reduction in the cloning efficiency of 1-ß-D-arabinofuranosylcytosine-resistant cells at high concentrations of F-ara-A may be due to some direct effect of the nucleoside. Finally, the different susceptibility of the mutant CCRF-CEM cells to the toxic effects of ara-A and F-ara-A suggests that alternative pathways phosphorylate these arabinonucleosides, one being associated with deoxycytidine kinase and the other with either deoxyadenosine kinase or, less likely, adenosine kinase.

¹ Supported by Research Project Grant CH-52A from the American Cancer Society, Research Project Grant CA-18446, Leukemia Program Project Grant CA-20180, Cancer Center Support (CORE) Grant CA-21764 from the National Cancer Institute, and American Lebanese Syrian Associated Charities (ALSAC).

² To whom requests for reprints should be addressed, at St. Jude Children's Research Hospital, 332 N. Lauderdale, P. O. Box 318, Memphis, Tenn. 38101.

Received 8/31/79. Accepted 1/29/80.

This article has been cited by other articles:

				H. Gourdeau, M. L. Clarke, F. Ouellet, D. Mowles, M. Selner, A. Richard, N. Lee, J. R. Mackey, J. D. Young, J. Jolivet, et al. Mechanisms of Uptake and Resistance to Troxacitabine, a Novel Deoxycytidine Nucleoside Analogue, in Human Leukemic and Solid Tumor Cell Lines Cancer Res., October 1, 2001; 61(19): 7217 - 7224. [Abstract] [Full Text] [PDF]